6OV7 | pdb_00006ov7

CFTR Associated Ligand (CAL) PDZ domain bound to peptide kCAL01


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.71 Å
  • R-Value Free: 
    0.214 (Depositor), 0.216 (DCC) 
  • R-Value Work: 
    0.182 (Depositor), 0.184 (DCC) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 6OV7

This is version 1.4 of the entry. See complete history

Literature

Computational Analysis of Energy Landscapes Reveals Dynamic Features That Contribute to Binding of Inhibitors to CFTR-Associated Ligand.

Holt, G.T.Jou, J.D.Gill, N.P.Lowegard, A.U.Martin, J.W.Madden, D.R.Donald, B.R.

(2019) J Phys Chem B 123: 10441-10455

  • DOI: https://doi.org/10.1021/acs.jpcb.9b07278
  • Primary Citation Related Structures: 
    6OV7

  • PubMed Abstract: 

    The CFTR-associated ligand PDZ domain (CALP) binds to the cystic fibrosis transmembrane conductance regulator (CFTR) and mediates lysosomal degradation of mature CFTR. Inhibition of this interaction has been explored as a therapeutic avenue for cystic fibrosis. Previously, we reported the ensemble-based computational design of a novel peptide inhibitor of CALP, which resulted in the most binding-efficient inhibitor to date. This inhibitor, kCAL01, was designed using osprey and evinced significant biological activity in in vitro cell-based assays. Here, we report a crystal structure of kCAL01 bound to CALP and compare structural features against iCAL36, a previously developed inhibitor of CALP. We compute side-chain energy landscapes for each structure to not only enable approximation of binding thermodynamics but also reveal ensemble features that contribute to the comparatively efficient binding of kCAL01. Finally, we compare the previously reported design ensemble for kCAL01 vs the new crystal structure and show that, despite small differences between the design model and crystal structure, significant biophysical features that enhance inhibitor binding are captured in the design ensemble. This suggests not only that ensemble-based design captured thermodynamically significant features observed in vitro , but also that a design eschewing ensembles would miss the kCAL01 sequence entirely.


  • Organizational Affiliation
    • Department of Computer Science , Duke University , Durham , North Carolina 27708 , United States.

Macromolecule Content 

  • Total Structure Weight: 21.14 kDa 
  • Atom Count: 1,645 
  • Modeled Residue Count: 191 
  • Deposited Residue Count: 194 
  • Unique protein chains: 2

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Golgi-associated PDZ and coiled-coil motif-containing protein
A, B
87Homo sapiensMutation(s): 0 
Gene Names: GOPCCALFIG
UniProt & NIH Common Fund Data Resources
Find proteins for Q9HD26 (Homo sapiens)
Explore Q9HD26 
Go to UniProtKB:  Q9HD26
PHAROS:  Q9HD26
GTEx:  ENSG00000047932 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ9HD26
Sequence Annotations
Expand
Reference Sequence
Find similar proteins by:  Sequence   |   3D Structure  
Entity ID: 2
MoleculeChains  Sequence LengthOrganismDetailsImage
kCAL01 peptide
C, D
10synthetic constructMutation(s): 0 

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.71 Å
  • R-Value Free:  0.214 (Depositor), 0.216 (DCC) 
  • R-Value Work:  0.182 (Depositor), 0.184 (DCC) 
Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 43.622α = 90
b = 60.767β = 90
c = 81.164γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
XDSdata reduction
XSCALEdata scaling
PHENIXphasing
PHENIXmodel building

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Disease (NIH/NIDDK)United StatesR01-DK101451
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United StatesT32-GM008704
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United StatesP20-GM113132
National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Disease (NIH/NIDDK)United StatesP30-DK117469

Revision History  (Full details and data files)

  • Version 1.0: 2019-11-20
    Type: Initial release
  • Version 1.1: 2019-11-27
    Changes: Database references
  • Version 1.2: 2019-12-25
    Changes: Author supporting evidence, Database references
  • Version 1.3: 2023-10-11
    Changes: Data collection, Database references, Refinement description
  • Version 1.4: 2024-10-30
    Changes: Structure summary